Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154
出版年份 2011 全文链接
标题
Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154
作者
关键词
-
出版物
BLOOD
Volume 118, Issue 4, Pages 1121-1131
出版商
American Society of Hematology
发表日期
2011-06-04
DOI
10.1182/blood-2010-12-322610
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans
- (2011) C. Stuehler et al. BLOOD
- Simultaneous Isolation of CD8+ and CD4+ T Cells Specific for Multiple Viruses for Broad Antiviral Immune Reconstitution After Allogeneic Stem Cell Transplantation
- (2011) Maarten L. Zandvliet et al. JOURNAL OF IMMUNOTHERAPY
- Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation
- (2010) K. P. Micklethwaite et al. BLOOD
- Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects
- (2010) J. J. Melenhorst et al. BLOOD
- Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation
- (2010) T. Feuchtinger et al. BLOOD
- Proliferative and cytotoxic responses to mannoproteins of Candida albicans by peripheral blood lymphocytes of HIV-infected subjects
- (2010) I. QUINTI et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Cytomegalovirus Seroprevalence in the United States: The National Health and Nutrition Examination Surveys, 1988–2004
- (2010) Sheri Lewis Bate et al. CLINICAL INFECTIOUS DISEASES
- Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database
- (2010) Dimitrios P. Kontoyiannis et al. CLINICAL INFECTIOUS DISEASES
- Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience
- (2010) Conrad Russell Cruz et al. CYTOTHERAPY
- Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation
- (2010) Ann M Leen et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection
- (2010) M. L. Zandvliet et al. HAEMATOLOGICA
- Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
- (2010) Ted A. Gooley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functional characterization of alloreactive T cells identifies CD25 and CD71 as optimal targets for a clinically applicable allodepletion strategy
- (2009) S. Samarasinghe et al. BLOOD
- Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation
- (2009) A. M. Leen et al. BLOOD
- CD137, implications in immunity and potential for therapy
- (2009) Elaine Thum Frontiers in Bioscience-Landmark
- Processing of Two Latent Membrane Protein 1 MHC Class I Epitopes Requires Tripeptidyl Peptidase II Involvement
- (2009) J. Diekmann et al. JOURNAL OF IMMUNOLOGY
- Immune Sensing of Aspergillus fumigatus Proteins, Glycolipids, and Polysaccharides and the Impact on Th Immunity and Vaccination
- (2009) S. Bozza et al. JOURNAL OF IMMUNOLOGY
- Exploiting Cytokine Secretion to Rapidly Produce Multivirus-specific T Cells for Adoptive Immunotherapy
- (2009) Yuriko Fujita et al. JOURNAL OF IMMUNOTHERAPY
- Cytotoxic T lymphocytes as immune-therapy in haematological practice
- (2008) Ann M. Leen et al. BRITISH JOURNAL OF HAEMATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started